DOI: 10.26717/BJSTR.2017.01.000133
*Corresponding author:
Andrew Korda AM, Royal Prince Alfred Hospital Medical Centre, Level 4, Room 404, 100 Carillon Avenue, Newtown, NSW 2042, AustraliaReceived: June 08, 2017 Published: June 15, 2017
To view the Full Article Peer-reviewed Article PDF
In the last twenty years, we have seen mesh used initially for the treatment of urinary incontinence with great efficacy and for pelvic organ prolapse, which in some women have had a negative impact and unexpected morbidity. This has resulted in issuing of warnings by regulatory authorities [1-5] the voluntary removal of some of these products from the market, adverse publicity in the media and an impending Senate Enquiry.